US Patent Issued to HANMI PHARM. on March 24 for "Pharmaceutical composite formulation comprising proton pump inhibitor and antacid" (South Korean Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,582,636, issued on March 24, was assigned to HANMI PHARM. Co. LTD. (Hwaseong-si, South Korea).

"Pharmaceutical composite formulation comprising proton pump inhibitor and antacid" was invented by Bo Sik Kim (Seoul, South Korea), Hyuk Jun Cho (Uiwang-si, South Korea), Ho Taek Im (Paju-si, South Korea) and Yong Il Kim (Gwacheon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "An aspect provides a pharmaceutical composite formulation containing: a first layer comprising a proton pump inhibitor or a pharmaceutically acceptable salt thereof as an active ingredient, a disintegrant, and a binder; and a second layer comprising, as an active ingred...